FDAnews
www.fdanews.com/articles/100884-middlebrook-pharmaceuticals-sells-product-line-to-bolster-financial-position

MiddleBrook Pharmaceuticals Sells Product Line to Bolster Financial Position

November 9, 2007

MiddleBrook Pharmaceuticals Inc. is selling its Keflex antibiotic line to a major shareholder for $7.5 million, money the biotech will use to continue negotiating a potential sale or partnership into next year.
Washington Business Journal